Literature DB >> 19401622

The decline of pharmaceutical psychiatry and the increasing role of psychological medicine.

Giovanni A Fava1.   

Abstract

The increasing influence of the pharmaceutical industry on psychiatric research and practice is leading to an intellectual and clinical crisis. A narrow concept of science attempts to apply oversimplified neurobiological models to the understanding and treatment of mental disorders, and relegates psychiatrists to a marginal role. This paper reviews some emerging trends of renewal that may be subsumed under the rubric of psychological medicine: use of a multidisciplinary approach, emphasis on psychotherapeutic strategies leading to self-management, reliance on repeated assessments, integration of different treatment modalities and independence from the pharmaceutical industry. The concept of psychological medicine, defined as the clinical application of the psychosomatic approach, may provide room for innovative paths in psychiatric research and treatment. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401622     DOI: 10.1159/000214443

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN: 0033-3190            Impact factor:   17.659


  6 in total

Review 1.  Psychosomatic medicine is a comprehensive field, not a synonym for consultation liaison psychiatry.

Authors:  Giovanni Andrea Fava; Carlotta Belaise; Nicoletta Sonino
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

2.  Are psychiatrists an endangered species? Observations on internal and external challenges to the profession.

Authors:  Heinz Katschnig
Journal:  World Psychiatry       Date:  2010-02       Impact factor: 49.548

Review 3.  New modalities of assessment and treatment planning in depression: the sequential approach.

Authors:  Giovanni A Fava; Elena Tomba
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

Review 4.  Tolerance to the prophylactic effects of carbamazepine and related mood stabilizers in the treatment of bipolar disorders.

Authors:  Robert M Post; Susan R B Weiss
Journal:  CNS Neurosci Ther       Date:  2010-12-16       Impact factor: 5.243

5.  Effect of group cognitive-behavioral therapy on the quality of life and social functioning of patients with mild depression.

Authors:  Boyuan Zhang; Xuefan Ding; Weihong Lu; Jing Zhao; Qinyu Lv; Zhenghui Yi; Shaoping Zhang; Yindi Chen
Journal:  Shanghai Arch Psychiatry       Date:  2016-02-25

6.  A Study of The Clinical Effect and Dropout Rate of Drugs Combined with Group Integrated Psychotherapy on Elderly Patients with Depression.

Authors:  Bo Liu; Youguo Tan; Duanfang Cai; Yudiao Liang; Ruini He; Chengwen Liu; Yong Zhou; Cuihua Teng
Journal:  Shanghai Arch Psychiatry       Date:  2018-02-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.